Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11883381
ASH1L inhibitors and methods of treatment therewith
granted -
US 11883386
Prolyl hydroxylase inhibitors and methods of use
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11884657
PI-kinase inhibitors with anti-infective activity
granted -
US 11878977
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 11872261
Lipoprotein targeting protease inhibitors and uses
granted -
US 11873288
Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)
granted -
US 11866418
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11866446
Inhibitors of APOL1 and methods of using same
granted -
US 11865125
APKC inhibitors and methods of treating a neurodegenerative disease or disorder
granted -
US 11865134
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11858957
Ectonucleotidase inhibitors and methods of use thereof
granted -
US 11858930
Fused bicyclic RAF inhibitors and methods for use thereof
granted -
US 11858937
Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
granted -
US 11858927
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11858925
GAS41 inhibitors and methods of use thereof
granted -
US 11851443
Neprilysin inhibitors
granted -
US 11845747
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
granted -
US 11845808
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11845989
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11840536
Heterocyclic inhibitors of PTPN11
granted -
US 11840540
Dimers of covalent NFKB inhibitors
granted -
US 11840525
Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer
granted